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Abstract  (150 words) 25 
 26 
Neohormone systems evolved specifically to regulate those mammalian traits, such 27 
as internal fertilization, pregnancy and lactation, which have proved to be central to 28 
the success, environmental independence, and adaptability of mammals as a 29 
vertebrate group. Neohormones such as oxytocin or relaxin are not only involved in 30 
the regulation of mammary gland development and function, but are also significant 31 
components of milk itself. Particularly for the latter hormone, it has been shown for 32 
the pig that relaxin in the first milk is taken up by the gastrointestinal tract of the 33 
offspring, enters the neonatal circulation and can have specific physiological and 34 
epigenetic effects on target organs such as the female reproductive system. 35 
Nevertheless, there are large gaps in our knowledge and understanding of such 36 
lactocrine systems especially in regard to other neohormones, species, and neonatal 37 
organ systems. 38 
 39 
 40 
 41 
 42 
 43 
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Introduction 45 
 46 
The evolutionary success of mammals has been largely due to the prolongation of 47 
early development within a physical environment which can be controlled to a large 48 
degree by the parent(s). For mammals this involved retention of the zygote, early 49 
embryo, and foetus within the mother until an advanced stage of development, when 50 
most organ systems are established and the resulting offspring is more or less 51 
independent. To achieve this, a series of sophisticated and interconnected 52 
evolutionary steps were essential (Table 1). Fertilization became internal, mostly 53 
within the oviduct. This in turn required the male to develop an intromittent organ, the 54 
penis, and more importantly behavioural changes to signal when an oocyte was 55 
mature and about to be released from an ovarian follicle. On the male side, there 56 
was a requirement for sperm storage within the epididymis, for behavioural 57 
modifications to ensure sexual congress at the appropriate time, and mechanisms to 58 
maintain sperm quiescence until ejaculation and then activation within the female 59 
tract. This in turn involved the evolution of exteriorized testes within a scrotum, 60 
presumably to allow sperm storage within the epididymis at a lower than abdominal 61 
temperature, such that upon ejaculation into the female tract the sperm are subject 62 
to a temperature jump of about 5oC, inducing capacitation. On the female side, there 63 
was requirement for intimate association of the growing embryo with the mother in 64 
the form of placentation, and importantly processes for physiological adjustment by 65 
the mother to recognize that she was pregnant (maternal recognition of pregnancy), 66 
accommodation of massively increased fluid volume relationships (osmotic 67 
adjustment), and immunological adjustment so that the genetically heterozygous 68 
embryo is not rejected by the maternal immune system. There needed to be a 69 
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mechanism regulating when the foetus was sufficiently developed to be expelled 70 
from the uterus, as well as all of the physiological mechanisms (birth contractions) 71 
required for this and its immediate sequelae (birth of the placenta; involution of the 72 
uterus and prevention of excessive bleeding). Finally, all of these processes required 73 
the accompaniment of highly developed behavioural adaptations to maximize 74 
survival of mother and offspring. 75 
 76 
Subsequent to pregnancy and birth, female mammals additionally added a further 77 
adaptation to offspring survival, namely the development of a mammary gland, 78 
lactation, and the provision of milk in response to birth and suckling. 79 
 80 
Besides the enormous organogenetic adaptations just mentioned, all of these also 81 
required highly coordinated endocrine and paracrine mechanisms for their induction 82 
and regulation. Perhaps surprisingly, the endocrine responsibility for these 83 
mammalian-specific physiological enhancements resides mostly within a relatively 84 
small group of hormones, termed ‘neohormones’ (1,2). These hormones effectively 85 
superimpose their functions onto those well-established endocrine systems, such as 86 
the hypothalamo-pituitary-gonadal (HPG) axis, already present in reptiles and lower 87 
vertebrates. The best known of the neohormones are those such as human chorionic 88 
gonadotropin (hCG) and oxytocin. But also members of the relaxin family of small 89 
peptide hormones are essentially involved in neohormone functions. These include 90 
besides relaxin (H2-relaxin) itself, also the structurally related molecules H1-relaxin, 91 
insulin-like peptide 3 (INSL3), INSL4, and INSL6, all of which are encoded by 92 
separate genes within the human genome. 93 
 94 
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Besides for oxytocin and relaxin, very little is known about their roles in the context of 95 
lactation. This is also surprising given that lactation can be seen as a logical 96 
continuation of internal fertilization, pregnancy and birth, wherein all neohormones by 97 
definition appear to be involved. Part of the reason for this lack of information is that 98 
until recently, there have been no specific assays with which to measure the 99 
presence of the relaxin family of peptide hormones in milk, and the fact that these 100 
peptides exhibit a large degree of species-specific variation, which mostly precludes 101 
the application of an assay from one species to another. Secondly, for some of these 102 
molecules, they may have a well-established classic role in a different physiological 103 
context, which has effectively blinded the scientist to look elsewhere. In this review, 104 
we shall critically assess what is known about the expression and role of these 105 
neohormone peptides specifically in the context of milk and lactation. 106 
 107 
Oxytocin 108 
 109 
Of all the neohormones, the nonapeptide hormone oxytocin is perhaps the most 110 
associated with lactation, being responsible for the milk let-down reflex during 111 
suckling. Pulsatile oxytocin is released from the posterior pituitary in response to 112 
vagal stimulation following infant suckling, and leads to contraction of the 113 
myoepithelial cells surrounding the mammary alveoli. This aspect has been 114 
adequately covered in other reviews (e.g. 3) and will not be discussed further here. 115 
What is less known is that oxytocin can be present in human milk at concentrations 116 
of between 0.01 and 18.9 ng/mL (4,5) and that oxytocin injected into post-parturient 117 
sows appears to increase leakiness of the alveolar tight junctions thereby increasing 118 
their permeability to serum factors (6), including to oxytocin itself. In breast-feeding 119 
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women, nursing significantly increases the concentration of OT in the milk (4). In 120 
cows, where milk yield may be enhanced by injections of oxytocin, concentrations of 121 
between 10 and 15 pg/mL are reported even after pasteurization (7), confirming what 122 
has been suggested elsewhere that oxytocin is quite stable in milk. There is almost 123 
no information on the impact in the neonate of oxytocin ingested with milk. One study 124 
in young rats (PND10-PND35) showed that oxytocin delivered by gavage could 125 
impact both body weight and ovarian physiology (8). Moreover, recent studies 126 
treating newborn monkeys with nebulized oxytocin do suggest that oxytocin 127 
delivered to the newborn in the perinatal period can have significant and positive 128 
impacts on the brain and behaviour (9,10). Together, such results do imply that 129 
oxytocin in milk, if available to the newborn in sufficient concentration, might have a 130 
positive effect on behaviour and/or physiology. 131 
 132 
 133 
Human chorionic gonadotrophin (hCG) 134 
 135 
Human chorionic gonadotrophin (hCG) is a paralogue of the pituitary gonadotrophin 136 
Luteinizing Hormone (LH) and is normally associated only with the early embryo in 137 
pregnancy, being part of human maternal recognition of pregnancy. It is assumed 138 
that there is none left in the circulation at the end of pregnancy and during lactation. 139 
However, in one case study of a woman who became pregnant while still breast-140 
feeding her previous child, hCG was indeed measured in her breast milk (512 141 
pmol/L) compared to 200,000 pmol/L in serum (11). Thus even though hCG is a 142 
large dimeric glycoprotein, sufficient appears to enter the milk during lactation to be 143 
measurable. Moreover, hCG has a much longer biological half-life compared to its 144 
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paralogue LH. Whether there are any effects in the infant is not known, though this is 145 
a concentration which could potentially activate the specific LH/hCG receptors, for 146 
example, in the neonatal gonads. 147 
 148 
 149 
Relaxin 150 
 151 
Most information is available for the hormone relaxin in milk. For humans, where 152 
there are three relaxin genes, this is the H2-relaxin principally made in and secreted 153 
from the ovary. Relaxin is synthesized initially as a single chain 14-18kD bioactive 154 
pro-hormone and is usually further processed within the Golgi and secretory vesicles 155 
to give rise to the normal 6kD heterodimeric hormone with a structure very like that 156 
for insulin (12). Depending on the species, relaxin is made in larger or smaller 157 
quantities by the ovary and in particular by the corpus luteum of pregnancy, whence 158 
it is secreted into the bloodstream to yield serum concentrations, for example, in the 159 
pig or rat, as high as 100 ng/ml (13) or 150ng/ml (14), respectively. Other species 160 
have usually much less relaxin in the blood. Importantly, relaxin is also expressed 161 
within the mammary gland itself (human (15); guineapig (16)), with 162 
immunohistochemistry identifying it in the human in the epithelial cells of the ducts 163 
and alveoli (17). Moreover, application of a neutralizing antibody in the rat showed 164 
that in this species almost all the relaxin in milk derives locally from within the 165 
mammary gland (18).  166 
 167 
There are numerous studies on the effects of relaxin on mammary gland 168 
development and physiology, acting via locally expressed specific relaxin receptors 169 
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(RXFP1) present in the parenchyma or on myoepithelial cells (19,20). However, 170 
studies using relaxin knockout mice emphasize that a key effect is less on gland 171 
development and milk production but rather on nipple enlargement (21) and in 172 
relaxin receptor deleted mice, there appears to be no evident mammary phenotype 173 
at all (22). This would tend to support the observations in animals (pigs, rats) where 174 
circulating relaxin alone has been eliminated (23,24). However, earlier studies in pigs 175 
emphasized that it is less relaxin on its own that is important for breast development, 176 
rather than when it acts synergistically with estrogens and/or progesterone (25).   177 
 178 
Irrespective of its source within the mammary gland or elsewhere in the body, relaxin 179 
has been identified in the milk from dog (26), human (27), rat (18), pig (28) and 180 
alpaca (29), ranging in concentration from 0.1 to 50ng/ml depending on the species 181 
and on the time during lactation. In porcine milk, relaxin appears to be present 182 
mostly as the 18kD bioactive pro-form rather than as the more usual 6kD mature 183 
heterodimer (28,30); whether this is true also for other species is not known. Relaxin, 184 
however, cannot be found in milk from cows or sheep since in these species the 185 
gene encoding relaxin has been naturally deleted from their genomes (31). Where it 186 
has been measured, maximal relaxin concentration appears to occur in the first milk 187 
(colostrum), during the first 24-48 hours after birth, and declines progressively 188 
thereafter. 189 
 190 
Importantly, at least in some species, there seems to be sufficient relaxin entering 191 
the stomachs of neonates in these first days of life for this to be able to cross the 192 
rather permeable gut lining and be present in physiologically relevant amounts in the 193 
neonate circulation (28). This has been especially shown for relaxin in the neonate 194 
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pig where, when nursed, these showed a circulating concentration of 180pg/ml, but 195 
undetectable relaxin when fed a milk-replacer or prior to suckling (28). Together such 196 
data support the “lactocrine hypothesis”, whereby milk presents important and 197 
developmentally relevant signalling molecules to the neonate in addition to fulfilling 198 
nutritional requirements (32). Numerous experiments confirm that naturally nursed 199 
animals support different developmental patterns of gene expression in the neonate 200 
compared to animals which have been fed with milk-replacer (33). Exogenously 201 
applied relaxin in replacer-fed pigs appears to decrease the expression specifically 202 
of the relaxin receptor RXFP1 in both uterus and cervix of the female neonates, thus 203 
impacting on the development of the female reproductive tract (34,35), and it is 204 
suggested that there is a similar impact also on early testicular development (33). In 205 
the pig at birth the uterus is developing rapidly, particularly in terms of the estrogen-206 
dependent growth of glandular tissue. Relaxin and its receptor RXFP1 appear to be 207 
intimately involved in this process (36), explaining why an absence of relaxin in milk 208 
might have significant epigenetic consequences on uterine development. Other 209 
possible impacts of lactocrine relaxin in this or any other species have not been 210 
specifically investigated, though are likely.  211 
 212 
INSL3 and other neohormones 213 
 214 
Of the remaining neohormones of the relaxin family of peptides, only for insulin-like 215 
peptide 3 (INSL3) do we have any information about its involvement in mammary 216 
gland physiology. Like the closely related hormone relaxin, INSL3 is expressed both 217 
as mRNA and protein within the tubule-alveolar epithelial cells of human breast 218 
tissue and not in stromal cells (37). Therefore analogously to relaxin one would 219 
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expect INSL3 to be detectable also in milk, though to date this has not been looked 220 
at for any species. In regard to other neohormones such as INSL4 and INSL6, there 221 
is no information available and cursory examination of the GEO microarray database 222 
does not suggest significant gene expression within mammary tissues. 223 
 224 
 225 
Research outlook 226 
 227 
It is clear from this survey that we still know very little about the physiological 228 
function of neohormones in milk for any species. The pioneering work on relaxin in 229 
the pig strongly supports the validity of the lactocrine hypothesis whereby hormones 230 
particularly in the first neonatal milk have an important role to play in establishing the 231 
epigenetic developmental landscape in the newborn mammal (32,33). From an 232 
evolutionary perspective it is very likely that other neohormone members will have 233 
similarly important roles. We know that the neonatal period represents an important 234 
and sensitive developmental window when the young mammal is particularly prone 235 
to the disruptive effects of environmental endocrine-acting chemicals, some of which 236 
are transported from the mother via milk (38). To date only impacts of milk-borne 237 
relaxin on the neonatal development of the female reproductive system have been 238 
investigated. Given that hormones like relaxin might also have impacts on other 239 
physiological systems which are developing rapidly in the young mammal, such as 240 
the cardiovascular (39), musculo-skeletal (40), or immune (41) systems, it is likely 241 
that the epigenetic importance of lactocrine neohormones is still widely 242 
underestimated. Another aspect which will need exploring is the mode of secretion 243 
and transport to the neonate. Whilst neohormones are mostly conventionally 244 
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secreted through the regulated pathway into extracellular fluids, there is no reason 245 
why in milk an apocrine process might not be used, employing exosomes released 246 
from the mammary epithelium. Moreover, this might explain why relaxin in porcine 247 
milk is largely present as the unprocessed bioactive pro-form. Apocrine secretion 248 
offers the advantage that the enclosed molecules are better protected against 249 
enzymatic attack in the neonate gastrointestinal tract. Also their mode of absorption 250 
through the gastrointestinal tract will require study; for example, one cannot assume 251 
that in older animals there is no transport of such peptide hormones across the gut 252 
lining. In fact, it has been shown that there are mechanisms which even allow the 253 
transport of molecules like INSL3 across the blood-testis barrier (42), foetal 254 
membranes (43), and the placenta (44). It is to be hoped that this nascent field of 255 
research on lactocrine neohormones will soon grow considerably. 256 
 257 
 258 
Summary 259 
 260 
Neohormones and their specific receptors have evolved to address all of the novel 261 
physiological and behavioural mechanisms that were essential for the emergence of 262 
mammals from lower vertebrates. Such new systems include internal fertilization and 263 
pregnancy, the development of a scrotal testis, and lactation, in addition to 264 
behavioural changes. The key molecules known to be involved in such neohormone 265 
functions include oxytocin as well as the relaxin-like family of peptide hormones. 266 
Although milk production is a typical mammalian trait, role of milk as an endocrine 267 
medium has been only sporadically investigated. Oxytocin, hCG and relaxin have all 268 
been identified as physiologically relevant neohormones in milk from various 269 
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species. Especially for relaxin in the pig, it has been clearly demonstrated that milk-270 
borne relaxin is taken up by the neonate and exerts significant developmental and 271 
epigenetic effects particularly on the neonate reproductive system. However, the 272 
field is characterized by large gaps in our knowledge about different species and 273 
target organs, and different hormones, and it is to be hoped that in the next years 274 
this deficit can in part be remedied. 275 
 276 
 277 
References 278 
 279 
1. Ivell R & Bathgate RAD. Hypothesis: Neohormone systems as exciting targets for drug 280 
development. Trends in Endocrinology and Metabolism 2006; 17, 123. 281 
 282 
2. *Anand-Ivell R, Dai Y & Ivell R. Neohormones as biomarkers of reproductive health. 283 
Fertility & Sterility 2013; 99: 1153-1160. 284 
 285 
3. Ivell R, Ludwig M, Tribe RM & Anand-Ivell R (2017) Oxytocin. In. Encyclopedia of 286 
Reproduction, 2nd edition (edited by Skinner M et al.) Elsevier (in press). 287 
 288 
4. Takeda S, Kuwabara Y & Mizuno M. Concentrations and origin of oxytocin in breast 289 
milk. Endocrinology, Japan 1986; 33: 821-826. 290 
 291 
5. Mishra M, Ali S & Das M. Analysis of oxytocin in milk samples and intake pattern in 292 
different age groups of Indian population. Toxicological Mechanisms & Methods 2014; 293 
24: 342-346. 294 
 295 
13 
 
6. Farmer C, Lessard M, Knight CH & Quesnel H. Oxytocin injections in the postpartal 296 
period affect mammary tight junctions in sows. Journal of Animal Science 2017; 95: 297 
3532-3539.  298 
 299 
7. Prakash BS, Paul V, Kliem H et al. Determination of oxytocin in milk of cows 300 
administered oxytocin. Analytica Chimica Acta 2009; 636: 111-115.  301 
 302 
8. Mishra M, Mishra V, Chaudhuri BP et al. Anomalies in ovary following oral exposure 303 
to oxytocin: mechanistic studies. Reproductive Toxicology 2013; 40: 24-34.  304 
 305 
9. Simpson EA, Paukner A, Sclafani V et al. Acute oxytocin improves memory and gaze 306 
following in male but not female nursery-reared infant macaques. 307 
Psychopharmacology 2017; 234: 497-506. 308 
 309 
10. Simpson EA, Sclafani V, Paukner A et al. Inhaled oxytocin increases positive social 310 
behaviors in newborn macaques. Proceedings of the National Academy of Sciences 311 
USA 2014; 111: 6922-6927. 312 
 313 
11. Sutton JM, Khanlian SA, Cole LA & Butler SA. HCG urinary metabolites in breast milk. 314 
Hormones & Metabolic Research 2004; 36: 75-77. 315 
 316 
12. Ivell R, Kotula-Balak M, Glynn D et al. Relaxin family peptides in the male reproductive 317 
system – a critical appraisal. Molecular Human Reproduction 2011; 17: 71-84. 318 
 319 
13. Sherwood OD, Chang CC, BeVier GW et al. Relaxin concentration in pig plasma 320 
following the administration of prostaglandin F2alpha during late pregnancy. 321 
Endocrinology 1976; 98: 875-879. 322 
14 
 
 323 
14. Sherwood OD & Crnekovic VE. Development of a homologous radioimmunoassay for 324 
rat relaxin. Endocrinology 1979; 104: 893-897. 325 
 326 
15. Bongers-Binder S, Burgardt A, Seeger H et al. Distribution of immunoreactive relaxin 327 
in the genital tract and in the mammary gland of non-pregnant women. Clinical and 328 
Experimental Obstetrics and Gynecology 1991; 18: 161-164. 329 
 330 
16. Peaker M, Taylor E, Tashima L et al. Relaxin detected by immunocytochemistry and 331 
northern analysis in the mammary gland of the guinea pig. Endocrinology 1989; 125: 332 
693-698. 333 
 334 
17. Tashima LS, Mazoujian G & Bryant-Greenwood GD. Human relaxins in normal, benign 335 
and neoplastic breast tissue. Journal of Molecular Endocrinology 1994; 12: 351-364. 336 
 337 
18. Steinetz BG, Horton L & Lasano S. The source and secretion of immunoreactive 338 
relaxin in rat milk. Experimental Biology & Medicine 2009; 234: 562-565. 339 
 340 
19. Min G & Sherwood OD. Identification of specific relaxin-binding cells in the cervix, 341 
mammary glands, nipples, small intestine, and skin of pregnant pigs. Biology of 342 
Reproduction 1996; 55: 1243-1252. 343 
 344 
20. Ivell R, Balvers M, Pohnke Y et al. Immunoexpression of the relaxin receptor LGR7 in 345 
breast and uterine tissues of humans and primates. Reproductive Biology & 346 
Endocrinology 2003; 1: 114. 347 
 348 
21. Zhao L, Roche PJ, Gunnersen JM et al. Mice without a functional relaxin gene are 349 
unable to deliver milk to their pups. Endocrinology 1999; 140: 445-453. 350 
15 
 
 351 
22. Parry LJ, Vodstrcil LA, Madden A et al. Normal mammary gland growth and lactation 352 
capacity in pregnant relaxin-deficient mice. Reproduction, Fertility & Development 353 
2009; 21: 549-560. 354 
 355 
23. Kass L, Ramos JG, Ortega HH et al. Relaxin has a minor role in rat mammary gland 356 
growth and differentiation during pregnancy. Endocrine 2001; 15: 263-269. 357 
 358 
24. Zaleski HM, Winn RJ, Jennings RL & Sherwood OD. Effects of relaxin on lactational 359 
performance in ovariectomized gilts. Biology of Reproduction 1996; 55: 671-675. 360 
 361 
25. Winn RJ, Baker MD, Merle CA & Sherwood OD. Individual and combined effects 362 
of relaxin, estrogen, and progesterone in ovariectomized gilts. II. Effects on mammary 363 
development. Endocrinology 1994; 135: 1250-1255. 364 
 365 
26. *Goldsmith LT, Lust G & Steinetz BG. Transmission of relaxin from lactating bitches to 366 
their offspring via suckling. Biology of Reproduction 1994; 50: 258-265. 367 
 368 
27. *Eddie LW, Sutton B, Fitzgerald S et al. Relaxin in paired samples of serum and milk 369 
from women after term and preterm delivery. American Journal of Obstetrics and 370 
Gynecology 1989; 161: 970-973. 371 
 372 
28. *Yan W, Wiley AA, Bathgate RA et al. Expression of LGR7 and LGR8 by neonatal 373 
porcine uterine tissues and transmission of milk-borne relaxin into the neonatal 374 
circulation by suckling. Endocrinology 2006; 147: 4303-4310. 375 
 376 
29. Volkery J, Gottschalk J, Sobiraj A et al. Progesterone, pregnanediol-3-glucuronide, 377 
relaxin and oestrone sulphate concentrations in saliva, milk and urine of female 378 
16 
 
alpacas (Vicugna pacos) and their application in pregnancy diagnosis. Veterinary 379 
Record 2012; 171: 195. 380 
 381 
30. *Frankshun AL, Ho TY, Reimer DC et al. Characterization and biological activity of 382 
relaxin in porcine milk. Reproduction 2011; 141: 373-380. 383 
 384 
31. Dai Y, Ivell R, Liu X et al. Relaxin-family peptide receptors 1 and 2 are fully functional 385 
in the bovine. Frontiers in Physiology 2017; 8: 359. 386 
 387 
32. *Bartol FF, Wiley AA, Miller DJ et al. Lactocrine signaling and developmental 388 
programming. Journal of Animal Science 2013; 91: 696-705. 389 
 390 
33. *Bagnell CA, Ho TY, George AF et al. Maternal lactocrine programming of porcine 391 
reproductive tract development. Molecular Reproduction & Development 2017; (epub 392 
ahead of print). 393 
 394 
34. *Chen JC, Frankshun AL, Wiley AA et al. Milk-borne lactocrine-acting factors affect 395 
gene expression patterns in the developing neonatal porcine uterus. Reproduction 396 
2011; 141: 675-683. 397 
 398 
35. Yan W, Chen J, Wiley AA et al. Relaxin (RLX) and estrogen affect estrogen receptor 399 
alpha, vascular endothelial growth factor, and RLX receptor expression in the neonatal 400 
porcine uterus and cervix. Reproduction 2008; 135: 705-712.  401 
 402 
36. *Bartol FF, Wiley AA & Bagnell CA. Relaxin and maternal lactocrine programming of 403 
neonatal uterine development. Annals of the New York Academy of Science 2009; 404 
1160: 158-163. 405 
 406 
17 
 
37. Hombach-Klonisch S, Buchmann J, Sarun S et al. Relaxin-like factor (RLF) is 407 
differentially expressed in the normal and neoplastic human mammary gland. Cancer 408 
2000; 89: 2161-2168. 409 
 410 
38. Gore AC, Chappell VA, Fenton SE et al. EDC-2: The Endocrine Society’s second 411 
scientific statement on endocrine-disrupting chemicals. Endocrine Reviews 2015; 36: 412 
E1-E150. 413 
 414 
39. Nistri S, Bigazzi M & Bani D. Relaxin as a cardiovascular hormone: physiology, 415 
pathoiphysiology and therapeutic promises. Cardiovascular & Hematological Agents in 416 
Medicinal Chemistry 2007; 5: 101-108. 417 
 418 
40. Ferlin A, De Toni L, Sandri M & Foresta C. Relaxin and insulin-like peptide 3 in the 419 
musculoskeletal system: from bench to bedside. British Journal of Pharmacology 420 
2017; 174: 1015-1024. 421 
 422 
41. Glynn DJ, Heng K, Russell D et al. Male seminal fluid relaxin contributes to induction 423 
of the post-mating cytokine response in the female mouse uterus. Frontiers in 424 
Physiology 2017; 8: 422.  425 
 426 
42. Anand-Ivell R, Heng K, Hafen B et al. Dynamics of INSL3  peptide expression in the 427 
rodent testis. Biology of Reproduction  2009; 81: 480-487. 428 
 429 
43. Vernunft A, Ivell R, Heng K, Anand-Ivell R. The male fetal biomarker INSL3 reveals 430 
substantial hormone exchange between fetuses in early pig gestation. PLOS One 431 
2016; 11: e0157954. 432 
 433 
18 
 
44. Anand-Ivell R, Hiendleder S, Viñoles C et al. INSL3 in the ruminant: a powerful 434 
indicator of gender- and genetic-specific feto-maternal dialogue. PLOS One 2011; 6: 435 
e19821. 436 
 437 
 438 
  439 
19 
 
 440 
Table 1 441 
 442 
Reproductive physiology and behaviour acquired with mammalian emergence 443 
and regulated by neohormone systems. 444 
 445 
 Viviparity and uterine accommodation of the embryo (placentation) 446 
 Internal fertilization and its coordination 447 
 Appropriate male and female sexual behaviour 448 
 Maternal recognition of pregnancy 449 
 Adjustment of cardiovascular function, as well as electrolyte and fluid balance in 450 
pregnancy 451 
 Adjustment of maternal immune tolerance to accommodate genetically different 452 
sperm and embryo 453 
 Thermoregulation and a constant core temperature 454 
 Regulation of the birth process and postnatal uterine involution and regeneration 455 
 Perinatal analgesia 456 
 Breast development and lactation 457 
 Appropriate maternal behaviour 458 
 Scrotal testes, testicular descent, and reduced scrotal temperature 459 
 Post-testicular sperm maturation, storage and capacitation as an adaptation to 460 
internal fertilization 461 
 Post-reproductive survival to provide extended care for offspring 462 
 463 
  464 
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Research Agenda 465 
 466 
 More information is required on the levels of different neohormones in milk from a 467 
range of species, including human, and their ability to withstand processing 468 
treatments. 469 
 470 
 Information is required on the time-course of neohormone expression in milk. 471 
whether in the first milk or after more prolonged lactation. 472 
 473 
 There is need for details on the biochemical format of bioactive neohormones in milk 474 
and its impact on hormone half-life. 475 
 476 
 What is the physiological and epigenetic relevance of neohormones in milk for the 477 
neonate, including information on mode of transport from the gastro-intestinal tract? 478 
 479 
 What is the mode of production and/or secretion from the mammary gland for any 480 
species, whether simple or apocrine secretion, or whether made locally or 481 
sequestered from the blood? 482 
 483 
